Literature DB >> 3821380

Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine.

E Giraldo, R Hammer, H Ladinsky.   

Abstract

In vitro competition binding experiments with the selective muscarinic antagonists AF-DX 116 and pirenzepine (PZ) vs 3H-N-methylscopolamine as radioligand revealed a characteristic distribution of muscarinic receptor subtypes in different regions of rat brain. Based on non linear least squares analysis, the binding data were compatible with the presence of three different subtypes: the M1 receptor (high affinity for PZ), the cardiac M2 receptor (high affinity for AF-DX 116) and the glandular M2 receptor (low affinity for PZ and AF-DX 116). The highest proportion of M1 receptors was found in the hippocampus, whilst the cerebellum and the hypothalamus were the regions with the largest fraction of the cardiac M2 and glandular M2 receptors, respectively. In certain brain areas, depending on the relative proportions of the subtypes, flat binding curves were seen for AF-DX 116 and PZ. Based on these data, an approximate distribution pattern of the subtypes in the various brain regions is presented.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3821380     DOI: 10.1016/0024-3205(87)90031-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Muscarinic suppression of the M-current in the rat sympathetic ganglion is mediated by receptors of the M1-subtype.

Authors:  N V Marrion; T G Smart; S J Marsh; D A Brown
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

Review 2.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  AFDX-116 discriminates between muscarinic M2 receptors of the heart and the iris smooth muscle.

Authors:  R E Honkanen; A A Abdel-Latif
Journal:  Mol Cell Biochem       Date:  1988 Jul-Aug       Impact factor: 3.396

4.  Cholinomimetic activities of minaprine.

Authors:  P Worms; J P Kan; R Steinberg; J P Terranova; A Perio; K Biziere
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

5.  Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.

Authors:  M H Richards
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

6.  Functional and binding studies with muscarinic M2-subtype selective antagonists.

Authors:  S Lazareno; F F Roberts
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.

Authors:  F Borsini; E Giraldo; E Monferini; G Antonini; M Parenti; G Bietti; A Donetti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

8.  Selectivity of oxomemazine for the M1 muscarinic receptors.

Authors:  S W Lee; C W Woo; J G Kim
Journal:  Arch Pharm Res       Date:  1994-12       Impact factor: 4.946

9.  Muscarinic receptor M1 and M2 subtypes in the human eye: QNB, pirenzipine, oxotremorine, and AFDX-116 in vitro autoradiography.

Authors:  N Gupta; R McAllister; S M Drance; J Rootman; M S Cynader
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

10.  Cloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover.

Authors:  R Stein; R Pinkas-Kramarski; M Sokolovsky
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.